rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Frank Zavrl

Director

Company insider

Files Form 4 as: Director, CervoMed; Director, Puma Biotechnology.

In numbers

Trades disclosed
14
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
2
First trade
8 Sep 2015
Last trade
8 Jun 2026
Last filed
10 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
CRVO CervoMedDirector · Biotechnology · last 8 Jun 20260 buys · 0 sells
PBYI Puma BiotechnologyDirector · Biotechnology · last 9 Jun 20200 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
8 Jun 2026filed 10 Jun 2026CRVO CervoMedoption or derivative · BiotechnologySEC FORM 4 Code A—8,150 at $0.00filing
8 Jun 2026filed 10 Jun 2026CRVO CervoMedoption or derivative · BiotechnologySEC FORM 4 Code A—8,150 at $0.00filing
23 Jun 2025filed 25 Jun 2025CRVO CervoMedoption or derivative · BiotechnologySEC FORM 4 Code A—8,100 at $0.00filing
14 Jun 2024filed 14 Jun 2024CRVO CervoMedoption or derivative · BiotechnologySEC FORM 4 Code A—5,750 at $0.00filing
15 Sep 2023filed 15 Sep 2023CRVO CervoMedoption or derivative · BiotechnologySEC FORM 4 Code A—6,450 at $0.00filing
9 Jun 2020filed 11 Jun 2020PBYI Puma BiotechnologyBiotechnologySEC FORM 4 Code A—25,748 at $0.00filing
10 Jun 2019filed 12 Jun 2019PBYI Puma BiotechnologyBiotechnologySEC FORM 4 Code A—19,423 at $0.00filing
12 Jun 2018filed 14 Jun 2018PBYI Puma BiotechnologyBiotechnologySEC FORM 4 Code A—5,822 at $0.00filing
12 Jun 2017filed 14 Jun 2017PBYI Puma Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—7,604 at $0.00filing
14 Nov 2016filed 16 Nov 2016PBYI Puma Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
14 Apr 2016filed 15 Apr 2016PBYI Puma Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
16 Dec 2015filed 18 Dec 2015PBYI Puma Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
8 Sep 2015filed 10 Sep 2015PBYI Puma Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
8 Sep 2015filed 10 Sep 2015PBYI Puma Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Matthew WintonChief Commercial and Business · Chief Commercial and Business at CervoMed, filing Form 4 there in the last year
Mark De RoschEVP, RA and GA and PgM · EVP, RA and GA and PgM at CervoMed, filing Form 4 there in the last year
Kelly BlackburnEVP, Clinical Development · EVP, Clinical Development at CervoMed, filing Form 4 there in the last year
Joshua S. BogerDirector and 10% owner · Director and 10% owner at CervoMed, filing Form 4 there in the last year
Marwan SabbaghDirector · Director at CervoMed, filing Form 4 there in the last year